In partnership with
December 4, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today we sit with a federal family that is opening a narrow door for hemp-derived CBD in Medicare even as Congress tightens a THC cap that reaches from beverages and balms to farm fields and bank risk. States and cities are already reacting, from Chicago and Ohio to Wisconsin, Kansas, and Minnesota, while courts, bankers, and ballot architects quietly redraw the map around them.
Today’s edition is supported by You.com and AltIndex.
💊 CBD, hemp caps, and federal lanes
🧊 Crackdowns, carveouts, and state pushback
🗳️ Courts, ballots, and shifting power maps
Make good decisions.
One major reason AI adoption stalls? Training.
AI implementation often goes sideways due to unclear goals and a lack of a clear framework. This AI Training Checklist from You.com pinpoints common pitfalls and guides you to build a capable, confident team that can make the most out of your AI investment.
What you'll get:
Key steps for building a successful AI training program
Guidance on overcoming employee resistance and fostering adoption
A structured worksheet to monitor progress and share across your organization
Start here — the day’s most important development, decoded for impact.
📌 What Happened: CMS is preparing a rule that would let Medicare Advantage plans cover certain hemp-derived CBD products that are legal under state and federal law. The move would unwind a prior stance that kept anything cannabis-related outside the world of supplemental benefits, even for seniors already using CBD at home. At the same time, Congress used the shutdown deal to rewrite the federal definition of hemp and cap total THC at 0.4 milligrams per container starting in 2026. That cap lands on most intoxicating hemp drinks and edibles and reaches into a slice of full-spectrum CBD, including oils, capsules, balms, pet products, and beverages that rely on trace THC. Federal policy now touches three familiar corners of the hemp economy in different ways: industrial and fiber projects, health and wellness CBD across multiple formats, and intoxicating products that behave more like low-dose cannabis. For a lot of people those distinctions are paperwork, not theory, because the same household can have a hempcrete renovation on the horizon, a CBD tincture on the nightstand, and a few milligram seltzers in the fridge.
💡 Why It Matters: Washington is starting to sort hemp by context instead of treating it as one thing. Industrial and fiber hemp still sit inside agriculture, infrastructure, and climate conversations, so they keep moving without much drama from the THC cap. Health and wellness CBD is being pulled toward a medical frame, where plans can ask for labeling, dosing logic, and outcomes data, and where a small universe of compliant products might eventually share shelf space with more traditional tools for pain, sleep, and anxiety. Intoxicating hemp, particularly when it moves through grocery, convenience, and bar channels instead of state cannabis stores, is absorbing the political anxiety that surrounded marijuana a decade ago. Different federal actors are pushing on different parts of the map: appropriators drew a hard numerical line, CMS is opening a narrow door for CBD in senior care, and FDA and USDA are still working off older Farm Bill assumptions. Taken together, these moves may draw the lines Washington is willing to own and the ones it intends to leave to states and private actors.
🧠 THC Group Take: If you run a hemp beverage brand, you probably spend part of your life in a boarding group at Reagan or BWI. The education curve on the Hill is steep, and a lot of members sit much closer to your grandparents’ habits than your customers’ buying patterns. CMS is moving because staff have spent years with data, benefit designs, and medical-necessity arguments, which is a key reminder of what makes federal actors more comfortable: standards, quality, and traceable maturity. Your job is to build that same case for your category, not only in Congress but through the state regulators who already license you, test your products, and watch how consumers actually use these drinks. Those regulators know where hemp beverages fit and they carry a credibility in Washington that industry voices rarely match on their own. If you can turn them into visible advocates for responsible, age-gated hemp products, you will be arguing for your place in the post-cap market with allies Congress still takes seriously.
Fast-moving headlines, flagged for what matters.
A new government-funded study in the International Journal of Drug Policy finds that state cannabis agencies describe and prioritize public health far more often than alcohol regulators, based on annual reports from all 24 adult-use states as of mid-2025. Researchers report that 68% of cannabis agencies reference public health goals in their mission statements, compared with just 35% of alcohol agencies, and cannabis regulators also check more boxes on concrete public health indicators. States that legalized through legislatures, rather than ballot initiatives, report more public health work for both cannabis and alcohol, which signals that later-wave adopters are quietly building more mature frameworks. The paper lands as Congress toys with new “regulate marijuana like alcohol” structures and as alcohol industry coalitions celebrate a federal ban on intoxicating hemp products they helped trigger. If federal lawmakers lean on the slogan without absorbing this data, they risk importing one of the country’s weaker public health models into a market that, on paper at least, is already trying to run ahead of it. (Marijuana Moment)
Five former U.S. Attorneys who served under President Biden say they never received a cannabis-specific policy memo telling them to avoid prosecuting simple marijuana possession, directly contradicting a key claim from the current U.S. Attorney in Wyoming. Darin Smith told DOJ and federal agencies this fall that Trump’s Justice Department had rescinded Biden-era “guidance” on simple possession and urged “rigorous” prosecution, framing his stance as a return to prior policy. The former U.S. Attorneys from Montana, Southern Ohio, South Carolina, New Mexico, and Northern Texas describe something closer to informal non-enforcement: scarce resources focused on fentanyl and violent crime, no written memo, and broad charging discretion under a general December 2022 Garland policy. Their comments also sit alongside Biden’s categorical pardons for federal simple-possession offenses and the unfinished Schedule 3 rescheduling effort, which created a clear political signal if not a formal memo. The gap between Smith’s narrative and his peers’ accounts sets up a potential test of how far Trump’s DOJ can lean on “secret guidance” to justify a harsher charging posture before Congress or the courts demand receipts. (Cannabis Business Times)
American Banker reports that Congress’s new ban on intoxicating hemp products is already chilling momentum on cannabis banking reform, with trade groups and lobbyists warning that lawmakers now see THC policy as politically radioactive again. The same offices that were inching toward bipartisan “safe harbor” language are suddenly fielding questions about kids, gummies, and gas-station products, which pushes risk-averse members back into wait-and-see mode. Bankers tell the outlet that shifting definitions of hemp and marijuana, plus the coming 0.4 milligram cap, make it harder to design compliance systems that cleanly separate legal deposits from banned activity. Advocates worry that Schedule 3 rescheduling will hit a Congress that just voted to crack down on hemp, with members wondering why they should take another vote that can be painted as soft on drugs. If this mood holds, the practical effect of the hemp crackdown will be fewer banks willing to expand cannabis relationships and a slower path to the normalized financial rails operators have been modeling into their future. (American Banker)
Minnesota’s hemp rules are barely settled and Republicans at the Capitol are already testing how far they can tighten the screws on low-dose THC. In a MinnPost op-ed, Rep. Angie Craig, now running for U.S. Senate, warns that GOP proposals would walk back the compromise that created Minnesota’s regulated hemp market and with it the ground rules that rural growers, small manufacturers, and local retailers used to justify real investment. She frames hemp as a pocketbook issue, arguing that lawmakers would be putting small-town jobs and tax receipts at risk to chase a “protect the kids” story they can already tell under existing law. The piece also serves as a campaign marker, pulling hemp out of the niche policy bucket and into the broader economic story Craig wants to tell statewide. If that framing takes hold, attempts to shrink the market will require legislators to own the local job losses that follow instead of hiding behind child-safety talking points. (MinnPost)
Wisconsin lawmakers have introduced a bipartisan bill that would move the state’s hemp program out from under USDA and into state control, then layer on age limits, lab testing, and packaging rules in an effort to keep the sector alive after the federal hemp crackdown hits next November. The proposal would require independent lab tests, child-resistant packaging, and a 21+ age gate for intoxicating hemp products, along with a 10-milligram THC cap per serving and a hard limit of two servings per package. Supporters argue that running a state-led program with tight rules gives Wisconsin a better chance of preserving a regulated hemp lane than simply watching the federal ban erase in-state demand. The bill also tweaks enforcement mechanics so prosecutors would not have to route every case through the agriculture department first, which is a quiet signal that lawmakers expect real, ongoing conflict over where to draw the line between compliant hemp and banned THC. (Ganjapreneur)
Kansas hemp farmers have worked their way into the top five producing states in the country, and now a new federal THC cap threatens to knock the legs out from under that progress. The shutdown-ending spending bill imposes a 0.4 milligram THC-per-container limit on hemp products starting next November, a rule aimed at intoxicating consumables that could still sweep in Kansas CBD businesses and spook buyers of industrial fiber and grain. Processors like Kancanna and Midwest Hemp Technologies tell reporters that even nonconsumable products are taking a hit as customers ask whether hemp-derived materials are “safe” to carry in the current political climate. Advocates warn that only pharmaceutical-grade or research operations might realistically hit the new threshold, and that without careful state implementation many farmers will simply quit or move their investment elsewhere. If Kansas lawmakers treat the federal change as a blanket crackdown instead of carving out clear lanes, they will be choosing to trade a rare rural growth sector for a talking point about closing loopholes. (The Lawrence Times)
Chicago’s License and Consumer Protection Committee has voted 10–6 to advance Ald. Marty Quinn’s ordinance that would ban most intoxicating hemp products from thousands of small retailers and confine sales to state-licensed dispensaries. The measure would take effect ten days after final passage and has drawn sharp opposition from beverage makers and corner-shop owners who packed the hearing to warn of job losses and scrapped expansion plans. The vote turns Chicago into one of the first major cities to try to translate Congress’s new federal hemp cap into a near-immediate local retail purge instead of waiting for the 2026 effective date. Crain’s reports that opponents on the council are already exploring ways to keep the ordinance from reaching the floor at the next meeting, which could buy time for business groups to press a licensing-and-testing compromise. Whatever happens next, Chicago’s fight will give other big-city councils a concrete sense of how quickly, and how bluntly, they can move against hemp once Washington opens the door. (Crain’s Chicago Business)
Ohio lawmakers are poised to pass a legislative package sold as a fix for intoxicating hemp that also rebuilds low-level criminal penalties and strips away civil protections voters thought they locked in with a ballot measure, Issue 2. The bill would make it a minor misdemeanor to bring cheaper cannabis home from Michigan, to drive with legal marijuana outside its original packaging, or to store products anywhere but the trunk, even as it leaves core adult-use rights nominally intact. It also unwinds protections around parenting, licensing, housing, and some public benefits, reopening the door for judges, boards, and landlords to treat lawful adult use as a character issue. NORML and key Democrats warn that the deal amounts to a quiet “recriminalization” of ordinary behavior that had been functionally legal since voters approved Issue 2 in 2023. If legislation reaches Gov. Mike DeWine’s desk and becomes law, Ohio will offer a live case study in how much risk and friction a legislature can bolt back onto a voter-approved legalization framework without touching the headline right to possess. (Signal Ohio)
Ballotpedia flags at least eight marijuana and psychedelics-related ballot measures that could reach 2026 ballots in six states, from Idaho’s already-certified move to lock legalization decisions inside the legislature to Alaska’s proposed decriminalization and regulation of psychedelics. Voters may also see measures to legalize adult-use in Nebraska, harden marijuana rights in Missouri, cut Washington’s cannabis excise tax from 37% to 7%, and repeal Massachusetts’ 2016 legalization framework while keeping small personal possession decriminalized. Idaho’s trio of measures alone captures the spread, with one initiative legalizing medical use, another decriminalizing adult use, and a third locking the door on citizen-led legalization going forward. If even a handful qualify, 2026 will test whether voters want to double down on legalization and tax relief, steer toward psychedelics access, or re-open fights that operators treated as settled. (Ballotpedia)
Nebraska’s Supreme Court is weighing whether to revive a lawsuit that aims to toss out tens of thousands of signatures for the state’s 2024 medical marijuana initiatives. Former state senator John Kuehn and Secretary of State Bob Evnen argue that widespread notary and circulator problems infected the Nebraskans for Medical Marijuana petitions, even though Evnen already certified the measures for the ballot last year. A Lancaster County judge found only 711 invalid signatures, far short of what would be needed to sink the petitions, and dismissed the case after the first phase of trial. At oral argument, justices pressed Evnen’s lawyer on what a second phase would look like and how a secretary of state can certify an initiative, then ask courts to pull it back while sidestepping questions about his own standing. The eventual ruling will signal how much room statewide officials have to reverse certification decisions and how hard opponents can lean on signature challenges after voters have already spoken. (Nebraska Public Media)
New Jersey’s Senate Judiciary Committee has advanced Senate President Nick Scutari’s bill that orders the State Police to build a formal enforcement program against unlicensed “legacy” shops while giving them power to shut stores, seize product, and refer cases for criminal prosecution. The same package would loosen ethics rules so certain state officials and their families can hold interests in cannabis companies with sign-off from ethics bodies, allow CRC commissioners to hold local elected office and campaign, and reduce the chair’s control by letting a majority of commissioners pick their own leader. It also trims municipal leverage by letting medical dispensaries convert to adult-use on-site without fresh local approval, and by limiting towns’ ability to block adult-use sales where compliant medical operators already exist. Read together, the bill pairs a harder edge on underground operators with a quiet redistribution of power inside the CRC and away from town halls, which is exactly the kind of structural shift that will matter more than any single raid or ribbon-cutting. (Heady NJ)
A new federal class action in Miami accuses Curaleaf of letting ad-tech vendors watch medical marijuana patients shop in real time on its website, including what they viewed, added to cart, and typed at checkout. The complaint says embedded scripts transmitted full URLs and contact details to Google, Sweed, AdPredictive, and StackAdapt, which allegedly turned those sessions into protected health information tied directly to identifiable patients. Lawyers cite HIPAA concepts, Florida’s strict rules for medical marijuana treatment centers, and federal and state wiretap laws to argue that Curaleaf “procured” third parties to intercept confidential medical communications without consent. The suit seeks nationwide and Florida-only classes, which suggests other multistate operators with aggressive tracking stacks should expect copycat litigation and regulator questions about who configured their pixels and why. (Miami New Times)
MJBizDaily surveys how cannabis executives are trying to build profitable models around a federal landscape that could stay frozen or change abruptly, with both scenarios carrying real risk. Panelists at MJBizCon describe rescheduling and 280E relief as essential but not transformative on their own, noting that capital access, interstate commerce, and banking could still lag far behind any CSA downgrade. Some operators are gaming out interstate strategies and dormant commerce clause challenges, while others are doubling down on discipline in their current footprints on the assumption that Congress and the White House will keep punting. The throughline is a kind of forced dual planning: companies need models that survive years of status quo while also staying nimble enough to pivot if rescheduling and hemp prohibition trigger new enforcement, pricing, and supply dynamics. The operators who hold those two truths at once, instead of betting the company on a political forecast, are the ones most likely to be around to benefit from any eventual reform. (MJBizDaily)
A new episode of The Big Story podcast asks whether Canada is squandering what should be an obvious advantage in cannabis tourism. Host Richard Southern and tourism researcher Susan Dupej sketch the gap between a country full of government-branded cannabis shops and a legal framework that offers tourists almost nowhere to consume safely or socially. Provinces have treated public consumption as a nuisance to minimize, not as an economic asset to manage, which keeps most activity in private rentals, gray-market lounges, or under-enforced public spaces. The conversation hints at a familiar risk: if governments refuse to design legitimate hospitality pathways, the vacuum fills with ad hoc workarounds that regulators eventually feel compelled to crack down on. For U.S. operators watching Canada as a preview of federal legalization, this is a quiet lesson that “legal” by itself does not build destination markets, zoning maps and licensing categories do. (CityNews)
Gotham and Cultivated Media are teaming up on The Highrise, a semi-annual salon that debuts January 29th at The Greene Space with a keynote conversation between Sen. Kirsten Gillibrand and Cultivated founder Jeremy Berke. The invite-only, $100 event is capped at 150 people and centers federal policy, science, “making cannabis investable again,” and the candid post-mortem on New York’s rollout that rarely makes it to conference main stages. The design is straightforward: put operators, investors, policymakers, and reporters in a room small enough that people stop speechifying and start saying what they actually think, then let that shape expectations around capital, enforcement, and timing. Cultivated are friends of this newsletter, and if you follow cannabis policy and finance closely you should have their work in your inbox alongside this one. If The Highrise lands the way it is drawn up, it will join the short list of rooms where the next phase of New York and federal cannabis policy gets sketched before anyone gives a quote on the record. (PR Newswire; Cultivated)
When AI Outperforms the S&P 500 by 28.5%
Did you catch these stocks?
Robinhood is up over 220% year to date.
Seagate is up 198.25% year to date.
Palantir is up 139.17% this year.
AltIndex’s AI model rated every one of these stocks as a “buy” before it took off.
The kicker? They use alternative data like reddit comments, congress trades, and hiring data.
We’ve teamed up with AltIndex to give our readers free access to their app for a limited time.
The next top performer is already taking shape. Will you be looking at the right data?
Past performance does not guarantee future results. Investing involves risk including possible loss of principal.
From the hearing room to the comment section — we’re watching it all.
🕊️ The Last Prisoner Project is running a holiday letter drive that matches volunteers with people still incarcerated on cannabis charges, offering short profiles and mailing details so supporters can write directly. It is a sharp reminder that “normalization” headlines and record sales sit alongside families spending another holiday without someone who went to prison for conduct that now feeds state tax receipts. (Last Prisoner Project)
🎸 George Clinton’s new Vegas shelf brand, The Funk, built with Wiz Khalifa’s Khalifa Kush, arrives with a blunt verdict on history: America “made more money pretending to stop weed than selling it.” It is a reminder that the modern celebrity cannabis wave sits on top of decades of criminalization and racialized enforcement that still shape who feels welcome in the legal market. (High Times)
🌏 Australia and New Zealand’s hemp sector is getting a joint industry report that maps growers, processors, and investors across both countries, with profiles spanning fiber, food, and cannabinoids. It is a bid to give policymakers and capital a single, credible story about hemp as climate-aligned agriculture instead of a scattered set of small projects. (HempToday)